US2014212891A1PendingUtilityA1
Compositions and Methods Using NOX5
Est. expiryJan 29, 2033(~6.5 yrs left)· nominal 20-yr term from priority
G01N 33/689G01N 33/573
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Certain embodiments include methods of assessing male fertility.
Claims
exact text as granted — not AI-modified1 . A method of assessing male fertility comprising extracting proteins from a sperm or semen sample obtained from a subject and measuring the level of NOX5 protein in the sperm or semen sample, wherein a level of NOX5 protein is at least 10 fold lower or at least 10 fold higher relative to a normal reference level is indicative of male infertility.
2 . The method of claim 1 , further comprising measuring protein levels for cAbl and HV1 proteins, wherein a decrease in protein levels is indicative of infertility.
3 . The method of claim 1 , wherein the level of NOX5 protein is at least 100 fold lower or at least 100 fold higher than a reference level.
4 . A method for in vitro diagnosis of male infertility comprising measuring the level of NOX5 protein in a sperm sample from a subject using at least one antibody that specifically binds NOX5; and diagnosing the subject with infertility when the level of NOX5 protein is decreased relative to a reference, the decreased level being indicative of infertility.
5 . The method of claim 3 , further comprising measuring protein levels for cAbl and HV1 proteins, wherein a decrease in protein levels is indicative of infertility.
6 . The method of claim 4 , wherein the level of NOX5 is at least 10 fold less or at least 10 fold more than a reference level.
7 . The method of claim 4 , wherein the level of NOX5 is at least 100 fold less or at least 100 fold more than a reference level.
8 . A method of assessing sperm function comprising extracting proteins from a sperm or semen sample obtained from a subject and measuring the level of NOX5 protein in the sperm or semen sample, wherein a decrease in the level of NOX5 protein relative to a normal reference level is indicative of reduced sperm motility.Join the waitlist — get patent alerts
Track US2014212891A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.